Alerts will be sent to your verified email
Verify Email
INDSWFTLAB
|
Ind-Swift Lab.
|
Shivalik Rasayan
|
Wanbury
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Total reactor capacity
|
700.0 kL | n/a | n/a |
|
DMF Filingsby API
|
474.0 . | n/a | n/a |
|
R&D as a % of Total Sales
|
3.01 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
9.6 % | 7.33 % | -30.56 % |
|
5yr average Equity Multiplier
|
2.49 | 1.84 | -3.1 |
|
5yr Average Asset Turnover Ratio
|
0.67 | 0.47 | 1.51 |
|
5yr Avg Net Profit Margin
|
6.7 % | 8.37 % | 7.58 % |
|
Price to Book
|
0.69 | 1.53 | 13.99 |
|
P/E
|
3.52 | 54.58 | 19.28 |
|
5yr Avg Cash Conversion Cycle
|
76.78 Days | 79.22 Days | -119.82 Days |
|
Inventory Days
|
126.74 Days | 63.09 Days | 20.62 Days |
|
Days Receivable
|
95.44 Days | 114.67 Days | 49.78 Days |
|
Days Payable
|
94.9 Days | 157.87 Days | 205.91 Days |
|
5yr Average Interest Coverage Ratio
|
3.49 | 10.93 | 2.36 |
|
5yr Avg ROCE
|
12.63 % | 9.58 % | -51.74 % |
|
5yr Avg Operating Profit Margin
|
19.31 % | 18.09 % | 4.22 % |
|
5 yr average Debt to Equity
|
1.22 | 0.16 | -0.61 |
|
5yr CAGR Net Profit
|
n/a | -1.91 % | -2.79 % |
|
5yr Average Return on Assets
|
7.66 % | 3.97 % | 11.1 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
40.94 % | 47.37 % | 39.63 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 76.74 % |
|
Change in Promoter Holding (3 Yrs)
|
-1.06 % | -2.95 % | -0.22 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Ind-Swift Lab.
|
Shivalik Rasayan
|
Wanbury
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
-
|